Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002)

· Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002), covering 2025-09-09 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT) [Phase 1]

See pricing